Alan W. Partin, MD, PhD

Alan W. Partin, MD, PhD

Johns Hopkins Medical Institutions

Baltimore, MD

Alan W. Partin is Chairman, David Hall McConnell Professor, and Chair of Urology at the Johns Hopkins Medical Institutions. He is also Urologist-in-Chief in the Department of Urology and Oncology at the Johns Hopkins Medical Institutions. Dr. Partin received his medical degree, a PhD, and completed his post-doctoral training at Johns Hopkins. Dr. Partin has both basic science and clinical interest in prognosis prediction for men with prostate cancer. His laboratories and clinical and surgical interests are focused on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians. Dr. Partin’s laboratories have investigated many new serum tests, some of which are soon to become available for the diagnosis of prostate cancer, as well as basic science investigation of new proteins, which may help in detection and staging of prostate cancer. In addition, Dr. Partin has an academic and clinical interest in the treatment of benign prostatic hyperplasia with an emphasis on minimally invasive techniques for the treatment of this common disease of men. Dr. Partin is a member of numerous societies and organizations, including the American Medical Association, the American Urological Association, and the Society for Basic Urologic Research. He currently serves on the Prostate Cancer Advisory Board of the American Cancer Society, on the Executive Committee of the National Cancer Institute Early Diagnostic Research Network, and is Editor-in-Chief of the journal Urology.

Articles by Alan W. Partin, MD, PhD

  • 1
  • 2

Join the GRU Community

- Why Join? -